Old Web
English
Sign In
Acemap
>
authorDetail
>
Ken Brasel
Ken Brasel
Amgen
Immunology
Stem cell
Haematopoiesis
Medicine
Stem cell factor
4
Papers
654
Citations
0.01
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Dramatic Numerical Increase of Functionally Mature Dendritic Cells in FLT3 Ligand-Treated Mice
1997
Advances in Experimental Medicine and Biology
Eugene Maraskovsky
Bali Pulendran
Ken Brasel
Mark Teepe
Eileen R. Roux
Ken Shortman
Stewart D. Lyman
Hilary J. McKenna
Show All
Source
Cite
Save
Citations (61)
FLT3 ligand: A new regulator of hematopoietic stem cells
1997
European Journal of Cancer
Stewart D. Lyman
Ken Brasel
Eugene Maraskovsky
Robert E. Miller
J. C. L. Schuh
Charlie Maliszewski
Bali Pulendran
Kim L. Stocking
Jacques J. Peschon
David R. Lynch
Hilary J. McKenna
Show All
Source
Cite
Save
Citations (0)
Plasma/serum levels of flt3 ligand are low in normal individuals and highly elevated in patients with Fanconi anemia and acquired aplastic anemia
1995
Blood
Stewart D. Lyman
Michelle Seaberg
Roberta Hanna
JoDee Zappone
Ken Brasel
Janis L. Abkowitz
Josef T. Prchal
John C. Schultz
Nasrollah T. Shahidi
Show All
Source
Cite
Save
Citations (103)
Molecular cloning of a ligand for the flt3 flk-2 tyrosine kinase receptor: A proliferative factor for primitive hematopoietic cells
1993
Cell
Stewart D. Lyman
Laura James
Tim Vanden Bos
Peter De Vries
Ken Brasel
Brian Gliniak
L.T. Hollingsworth
Kathleen S. Picha
Hilary J. McKenna
Roxanne R. Splett
Frederick A. Fletcher
Eugene Maraskovsky
Terry Farrah
Diane Foxworthe
Douglas E. Williams
M. Patricia Beckmann
Show All
Source
Cite
Save
Citations (490)
1